Live Breaking News & Updates on Heba Nowyhed|Page 1

Stay updated with breaking news from Heba nowyhed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures

/PRNewswire/ Kyverna Therapeutics ("Kyverna"), a cell therapy company engineering a new class of therapies for serious autoimmune diseases, today announced. ....

Brian Kotzin , Biopartners Westlake , Iconovir Bio , Chris Liu , Fred Cohen , Danielk Spiegelman , Mark Genovese , Ian Clark , Dominic Borie , Desmond Padhi , Beth Seidenberg , Heba Nowyhed , Ishaan Gandhi , Gilead Sciences , Gilead Company , Nektar Therapeutics , National Institutes Of Health , Tizona Therapeutics Inc , Rigel Pharmaceuticals , Westlake Village Biopartners , Vida Ventures , Insight Partners , Intellia Therapeutics , Argentum Peak , Hudson Bay Capital , National Institutes ,

Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: New Investment in Kyverna

Investegate announcements from RTW Venture Fund Ltd, New Investment in Kyverna ....

City Of , United Kingdom , Brian Kotzin , Biopartners Westlake , Fred Cohen , Charles Ryland , Mark Genovese , Stephanie Sirota , Dominic Borie , Beth Seidenberg , Heba Nowyhed , Ishaan Gandhi , Iconovir Bio , Chris Liu , Alexandra Taracanova , Danielk Spiegelman , Julia Enright , Henry Wilson , Ryan Jones , Ian Clark , Kathy Vincent , Desmond Padhi , George Beale , Venture Fund Limited The Company , Gilead Sciences , Venture Fund ,

Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures

/PRNewswire/ Kyverna Therapeutics ("Kyverna"), a cell therapy company engineering a new class of therapies for serious autoimmune diseases, today announced. ....

Brian Kotzin , Biopartners Westlake , Iconovir Bio , Chris Liu , Fred Cohen , Danielk Spiegelman , Mark Genovese , Ian Clark , Dominic Borie , Desmond Padhi , Beth Seidenberg , Heba Nowyhed , Ishaan Gandhi , Gilead Sciences , Gilead Company , Nektar Therapeutics , National Institutes Of Health , Tizona Therapeutics Inc , Rigel Pharmaceuticals , Westlake Village Biopartners , Vida Ventures , Insight Partners , Intellia Therapeutics , Argentum Peak , Hudson Bay Capital , National Institutes ,